X74.F I.M.D. International Medical Devices S.p.A.
- Market cap
- EUR 19.7M
- P/E
- 16.3x
- P/B
- 0.92x
- ROE
- 6.1%
- Dividend yield
- 8.77%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is X74.F undervalued?
Graham numberX74.F trades 18.3% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
I.M.D. International Medical Devices S.p.A. fundamental analysis
No fundamental analysis for I.M.D. International Medical Devices S.p.A. yet.
I.M.D. International Medical Devices S.p.A. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About I.M.D. International Medical Devices S.p.A.
I.M.D. International Medical Devices S.p.A. designs, develops, manufactures, and markets a range of diagnostic systems with X-ray technology in Italy and internationally. The company provides components for clinical applications in the radiology and medical fields. It also offers x-ray generators that include monoblocks, RX generators, and control systems, as well as x-ray imagining devices used in orthopaedic, urology, and operating theatres. The company was founded in 1998…
Full company profileI.M.D. International Medical Devices S.p.A. financial statements
I.M.D. International Medical Devices S.p.A. annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 46.9M | 42.0M | 38.3M | 39.4M | 34.5M |
| Gross Profit | 18.2M | 17.4M | 16.0M | 15.5M | 13.8M |
| Operating Income | 7.17M | 5.45M | 3.97M | 3.55M | 2.06M |
| EBITDA | - | 5.42M | 4.32M | 3.91M | 2.61M |
| Net Income | 4.12M | 2.93M | 2.22M | 2.23M | 1.40M |
| EPS | 0.24 | 0.17 | 0.13 | 0.13 | 0.08 |
| Balance Sheet | |||||
| Total Assets | 33.7M | 32.8M | 36.2M | 35.7M | 32.9M |
| Total Liabilities | 21.3M | 17.4M | 13.0M | 12.4M | 9.91M |
| Shareholders' Equity | 11.0M | 13.9M | 21.5M | 23.3M | 23.0M |
| Cash & Short-term Investments | 6.74M | 3.01M | 4.55M | 8.34M | 8.35M |
| Cash Flow | |||||
| Operating Cash Flow | 3.23M | -4.87M | -1.31M | 8.05M | 2.31M |
| Capital Expenditure | 30.0K | 429K | 1.60M | 645K | 578K |
| Free Cash Flow | 3.20M | -5.30M | -2.91M | 7.41M | 1.73M |
| Ratios | |||||
| ROE | 37.6% | 21.1% | 10.3% | 9.6% | 6.1% |
| ROA | 12.2% | 8.9% | 6.1% | 6.2% | 4.2% |
| Net Profit Margin | 8.8% | 7.0% | 5.8% | 5.7% | 4.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
I.M.D. International Medical Devices S.p.A. dividends
- Dividend yield
- 8.77%
- Forward dividend
- 0.07 EUR
- Payout ratio
- 123.9%
- Ex-dividend date
- Apr 27, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | EUR 1.73M | 0.10 | 123.9% |
| 2024 | EUR 1.12M | 0.06 | 50.4% |
| 2023 | EUR 84.0K | 0.00 | 3.8% |
| 2022 | EUR 134K | 0.01 | 4.6% |
| 2021 | EUR 67.0K | 0.00 | 1.6% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns I.M.D. International Medical Devices S.p.A.
- Insiders 85.35%
- Institutions 1.45%
- Public & others 13.20%
- Shares outstanding 17.3M
- Free float 3.81M
I.M.D. International Medical Devices S.p.A. company profile
- Company name
- I.M.D. International Medical Devices S.p.A.
- Ticker
- X74.F
- ISIN
- IT0005549255
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 108
- Fiscal year end
- December
- Address
- Via Enrico Fermi n. 26, Grassobbio, BG, Italy, 24050
- Phone
- 39 035 65 94 811
- Website
- imdgroup.it
About I.M.D. International Medical Devices S.p.A.
I.M.D. International Medical Devices S.p.A. designs, develops, manufactures, and markets a range of diagnostic systems with X-ray technology in Italy and internationally. The company provides components for clinical applications in the radiology and medical fields. It also offers x-ray generators that include monoblocks, RX generators, and control systems, as well as x-ray imagining devices used in orthopaedic, urology, and operating theatres. The company was founded in 1998 and is headquartered in Grassobbio, Italy. I.M.D. International Medical Devices S.p.A. operates as a subsidiary of Alefra S.R.L.
I.M.D. International Medical Devices S.p.A. management
3- Mr. Aniello AlibertiChairman & CEO · born 1957
- Mr. Gabriele PatelliMD, CFO & Director · born 1963
- Mr. Luca ConcaMD & Director · born 1979